“The UFC organization was formally notified today that the U.S. Anti-Doping Agency (USADA) has informed George Sullivan of a potential Anti-Doping Policy violation stemming from an out-of-competition sample collection taken on January 14, 2017. Sullivan is currently serving a one year suspension under the UFC Anti-Doping Program, for his use of a product containing the prohibited substance Insulin Growth Factor -1 (IGF-1).  Sullivan was due to end his current suspension on January 31, 2017, and compete on the UFC 208 card in Brooklyn, New York, against Randy Brown.  However, US … Read the Full Article Here
Source: UFC